AASLD: Early Study Shows HCV Vaccine Works (CME/CE)

BOSTON (MedPage Today) — An experimental therapeutic vaccine against hepatitis C improved response rates by 12% compared with standard care in a small clinical trial, a researcher reported here.

Post a Comment

Comments are closed.